Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors

Journal Article · · Bioorganic and Medicinal Chemistry
Molecular modeling of unbound tricyclic guanine scaffolds indicated that they can serve as effective bioisosteric replacements of xanthines. This notion was further confirmed by a combination of X-ray crystallography and SAR studies, indicating that tricyclic guanine DPP4 inhibitors mimic the binding mode of xanthine inhibitors, exemplified by linagliptin. Realization of the bioisosteric relationship between these scaffolds potentially will lead to a wider application of cyclic guanines as xanthine replacements in drug discovery programs for a variety of biological targets. Newly designed DPP4 inhibitors achieved sub-nanomolar potency range and demonstrated oral activity in vivo in mouse glucose tolerance test.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1404974
Journal Information:
Bioorganic and Medicinal Chemistry, Journal Name: Bioorganic and Medicinal Chemistry Journal Issue: 21 Vol. 24; ISSN 0968-0896
Publisher:
Elsevier
Country of Publication:
United States
Language:
ENGLISH

Similar Records

Pyrazolo-Pyrimidines: A Novel Heterocyclic Scaffold for Potent and Selective p38alpha Inhibitors
Journal Article · Mon Dec 31 23:00:00 EST 2007 · BioOrganic and Medicinal Chemistry Letters · OSTI ID:959850

Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from [beta]-Aminoamides Bearing Subsituted Triazolopiperazines
Journal Article · Mon Jun 30 00:00:00 EDT 2008 · J. Med. Chem. · OSTI ID:1006511

Aminopiperidine-Fused Imidazoles as Dipeptidyl Peptidase-IV Inhibitors
Journal Article · Wed Dec 31 23:00:00 EST 2008 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:980003